Skip to content
The Nexus
DossierENTITY

EFPIA

Coverage of EFPIA in the Nexus archive.

Earliest in view: Jun 17 · 03:00 UTCMost recent: Jun 17 · 03:00 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJun 17 · 03:00 UTCPOLITICO EUROPE
    Do we want to lead or lag in life sciences?

    Europe risks losing its leadership in the pharmaceutical sector due to geopolitical challenges and internal indifference, with the United States' Most-Favored-Nation pricing policy and China's rapid advancements in biotechnology and innovation exacerbating the decline. Europe lags behind in clinical trials, R&D spending, and attracting investment compared to the US and China.